Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: July 12, 2005
Last updated: June 3, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)